Vertex Pharmaceuticals (VX1.F) Q1 2026 Earnings

12FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
3.59
3.83
4.07
4.31

Details

Expected EPS
4.30588239638
Actual EPS
4.2379762
Surprise EPS
-0.07
Surprise Percent
+1.58%

Description

Vertex Pharmaceuticals (VX1.F) has reported earnings of 4.2379762 per share for Q1 2026.

0 Comments

Share your thoughts